Literature DB >> 9914881

Mechanisms of apoptosis avoidance in cancer.

J C Reed1.   

Abstract

Defects in the programmed cell death mechanisms can extend cell lifespan, contributing to neoplastic cell expansion independently of cell division. Deficiencies in apoptosis also contribute to carcinogenesis by creating a permissive environment for genetic instability and accumulation of gene mutations, permitting disobeyance of cell cycle checkpoints which would normally induce apoptosis, facilitating growth factor- and hormone-independent cell survival, supporting anchorage-independent survival during metastasis, reducing dependence on oxygen and nutrients, promoting resistance to immune-based destruction, and conferring resistance to cytotoxic anticancer drugs and radiation. Though much remains to be learned, identification of gene families that control the physiological cell death pathway has provided the basis for improved understanding of tumor biology. This review describes some of the recent progress made towards delineating the biochemistry and molecular biology of apoptosis control, and briefly summarizes the progress in identifying specific road blocks to apoptosis induction in cancers. These advances are beginning to reveal novel strategies for combating cancer by restoring apoptosis sensitivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914881     DOI: 10.1097/00001622-199901000-00014

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  68 in total

1.  Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation.

Authors:  R G Deschesnes; J Huot; K Valerie; J Landry
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

Review 2.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

3.  RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.

Authors:  Zahra Shahsavari; Fatemeh Karami-Tehrani; Siamak Salami; Mehran Ghasemzadeh
Journal:  Tumour Biol       Date:  2015-10-26

Review 4.  DNA double-strand breaks: a potential causative factor for mammalian aging?

Authors:  Han Li; James R Mitchell; Paul Hasty
Journal:  Mech Ageing Dev       Date:  2008-02-14       Impact factor: 5.432

5.  Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells.

Authors:  T V Achenbach; E P Slater; H Brummerhop; T Bach; R Müller
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Stereoselective synthesis of the disaccharide unit of incednine.

Authors:  Jason R Abbott; William R Roush
Journal:  Org Lett       Date:  2012-12-18       Impact factor: 6.005

7.  Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.

Authors:  Luigi Aloj; Antonella Zannetti; Corradina Caracó; Silvana Del Vecchio; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-10       Impact factor: 9.236

8.  4beta-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest.

Authors:  Ching-Yu Yen; Chien-Chih Chiu; Fang-Rong Chang; Jeff Yi-Fu Chen; Chi-Ching Hwang; You-Cheng Hseu; Hsin-Ling Yang; Alan Yueh-Luen Lee; Ming-Tz Tsai; Zong-Lun Guo; Yu-Shan Cheng; Yin-Chang Liu; Yu-Hsuan Lan; Yu-Ching Chang; Ying-Chin Ko; Hsueh-Wei Chang; Yang-Chang Wu
Journal:  BMC Cancer       Date:  2010-02-18       Impact factor: 4.430

9.  Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.

Authors:  Yanyuan Wu; Monica Alvarez; Dennis J Slamon; Phillip Koeffler; Jaydutt V Vadgama
Journal:  BMC Cancer       Date:  2010-02-04       Impact factor: 4.430

10.  Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.

Authors:  J Kikuchi; I Kinoshita; Y Shimizu; S Oizumi; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.